Advertisement

Loading...

Relief Therapeutics Holding AG

RLFTF•PNK
Healthcare
Biotechnology
$0.43
$-0.02(-5.37%)
U.S. Market is Open • 11:24

Relief Therapeutics Holding AG (RLFTF) Stock Overview

Explore Relief Therapeutics Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.2M
P/E Ratio-0.24
EPS (TTM)$-1.70
ROE-0.49%
Fundamental Analysis

AI Price Forecasts

1 Month$1.57
3 Months$0.00
1 Year Target$3.13

RLFTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Relief Therapeutics Holding AG (RLFTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 20.03, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $3.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.24 and a market capitalization of 5.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.72%
5-Day Change
-19.18%
1-Month Change
-54.80%
3-Month Change
-82.75%
6-Month Change
-90.06%
Year-to-Date (YTD) Change
-82.96%
1-Year Change
-84.78%
3-Year Change
-95.45%
5-Year Change
-99.68%
All-Time (Max) Change
-97.40%

Contact Information

https://mindmazetherapeutics.com
41 21 552 08 01
Chemin de Roseneck 5, Lausanne, NaN, 1202

Company Facts

310 Employees
IPO DateJan 8, 2021
CountryCH
Actively Trading

Frequently Asked Questions